Np mrd loader

Record Information
Version2.0
Created at2022-04-29 04:50:59 UTC
Updated at2022-04-29 04:50:59 UTC
NP-MRD IDNP0083968
Secondary Accession NumbersNone
Natural Product Identification
Common NameDoxorubicin
DescriptionDoxorubicin, also known as adriamycin or adriblastina, belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom. Thus, doxorubicin is considered to be an aromatic polyketide lipid molecule. Doxorubicin is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Doxorubicin exists in all living organisms, ranging from bacteria to humans. Within humans, doxorubicin participates in a number of enzymatic reactions. In particular, doxorubicin can be converted into doxorubicinol deoxaglycone through the action of the enzymes nad(p)H dehydrogenase [quinone] 1, nadph--cytochrome P450 reductase, and xanthine dehydrogenase/oxidase. In addition, doxorubicin can be converted into doxorubicinol; which is mediated by the enzymes carbonyl reductase [nadph] 1, carbonyl reductase [nadph] 3, aldo-keto reductase family 1 member C3, and alcohol dehydrogenase [nadp(+)]. In humans, doxorubicin is involved in doxorubicin metabolism pathway. Doxorubicin is formally rated as a probable carcinogen (by IARC 2A) and is also a potentially toxic compound. Doxorubicin is found in Dracocephalum kotschyi, Ixora coccinea, Streptomyces galilaeus, Streptomyces peucetius, Streptomyces venezuelae and Xylopia laevigata. Doxorubicin was first documented in 1969 (PMID: 5365804). People often experience red discoloration of the urine for a few days (PMID: 1462166) (PMID: 2555273) (PMID: 5772652).
Structure
Thumb
Synonyms
ValueSource
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosideChEBI
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedioneChEBI
14-HydroxydaunomycinChEBI
14-HydroxydaunorubicineChEBI
AdriamycinChEBI
DoxorubicineChEBI
DoxorubicinumChEBI
ADRKegg
AdriblastinaKegg
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosideGenerator
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosideGenerator
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedioneGenerator
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedioneGenerator
AdriablastinHMDB
AdriblastinHMDB
Baxter brand OF doxorubicin hydrochlorideHMDB
Doxorubicin hydrochlorideHMDB
Doxorubicina ferrer farmHMDB
Ferrer brand OF doxorubicin hydrochlorideHMDB
Onkoworks brand OF doxorubicin hydrochlorideHMDB
Urokit doxo-cellHMDB
Ribosepharm brand OF doxorubicin hydrochlorideHMDB
AdrimedacHMDB
Bedford brand OF doxorubicin hydrochlorideHMDB
Doxorubicin hexalHMDB
Doxorubicin NCHMDB
Doxorubicina funkHMDB
DoxotecHMDB
Kenfarma brand OF doxorubicin hydrochlorideHMDB
Prasfarma brand OF doxorubicin hydrochlorideHMDB
RubexHMDB
Tedec meiji brand OF doxorubicin hydrochlorideHMDB
Cell pharm brand OF doxorubicin hydrochlorideHMDB
AdriblastineHMDB
Columbia brand OF doxorubicin hydrochlorideHMDB
Doxo cellHMDB
Doxo-cellHMDB
Elan brand OF doxorubicin hydrochlorideHMDB
FarmiblastinaHMDB
Lemery brand OF doxorubicin hydrochlorideHMDB
MyocetHMDB
OnkodoxHMDB
RibodoxoHMDB
AdriablastineHMDB
Bristol-myers squibb brand OF doxorubicin hydrochlorideHMDB
DoxolemHMDB
Doxorubicina tedecHMDB
Doxorubicine baxterHMDB
Hexal brand OF doxorubicin hydrochlorideHMDB
Hydrochloride, doxorubicinHMDB
Neocorp brand OF doxorubicin hydrochlorideHMDB
Pfizer brand OF doxorubicin hydrochlorideHMDB
Urokit doxo cellHMDB
Medac brand OF doxorubicin hydrochlorideHMDB
Chemical FormulaC27H29NO11
Average Mass543.5193 Da
Monoisotopic Mass543.17406 Da
IUPAC Name(8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
Traditional Namedoxorubicin
CAS Registry NumberNot Available
SMILES
COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O
InChI Identifier
InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1
InChI KeyAOJJSUZBOXZQNB-TZSSRYMLSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Dracocephalum kotschyiLOTUS Database
Ixora coccineaLOTUS Database
Streptomyces galilaeusLOTUS Database
Streptomyces peucetiusLOTUS Database
Streptomyces venezuelaeLOTUS Database
Xylopia laevigataPlant
Chemical Taxonomy
Description Belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentGamma amino acids and derivatives
Alternative Parents
Substituents
  • Gamma amino acid or derivatives
  • Amino fatty acid
  • Fatty acyl
  • Amino acid
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organopnictogen compound
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Amine
  • Primary aliphatic amine
  • Organic oxygen compound
  • Carbonyl group
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Aliphatic homomonocyclic compound
Molecular FrameworkAliphatic homomonocyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP1.41ALOGPS
logP0.92ChemAxon
logS-2.7ALOGPS
pKa (Strongest Acidic)9.53ChemAxon
pKa (Strongest Basic)8.94ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count12ChemAxon
Hydrogen Donor Count6ChemAxon
Polar Surface Area206.07 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity134.59 m³·mol⁻¹ChemAxon
Polarizability53.87 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDHMDB0015132
DrugBank IDDB00997
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID29400
KEGG Compound IDC01661
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkDoxorubicin
METLIN IDNot Available
PubChem Compound31703
PDB IDNot Available
ChEBI ID28748
Good Scents IDNot Available
References
General References
  1. Weiss RB: The anthracyclines: will we ever find a better doxorubicin? Semin Oncol. 1992 Dec;19(6):670-86. [PubMed:1462166 ]
  2. Minotti G: Reactions of adriamycin with microsomal iron and lipids. Free Radic Res Commun. 1989;7(3-6):143-8. doi: 10.3109/10715768909087936. [PubMed:2555273 ]
  3. Arcamone F, Cassinelli G, Fantini G, Grein A, Orezzi P, Pol C, Spalla C: Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol Bioeng. 1969 Nov;11(6):1101-10. doi: 10.1002/bit.260110607. [PubMed:5365804 ]
  4. Di Marco A, Gaetani M, Scarpinato B: Adriamycin (NSC-123,127): a new antibiotic with antitumor activity. Cancer Chemother Rep. 1969 Feb;53(1):33-7. [PubMed:5772652 ]